Zalutumumab in Patients With Non-curable Head and Neck Cancer

Clinical trial NCT00382031 · COMPLETED

Trial details

NCT number: NCT00382031
Sponsor: Genmab
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Head and Neck Cancer Squamous Cell Cancer

Start date: 2006-11-01
Primary completion: 2009-12-01
Enrollment: 286

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.